US Edition
Swiss insurers fear cost explosion from weight loss drug
Summary by Le News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Swiss insurers fear cost explosion from weight loss drug
Since March 2024, Switzerland’s basic health insurance started reimbursing part of the cost of Wegovy, a weight-loss drug developed by Danish pharmaceutical giant Novo Nordisk. The decision has led to a surge in uptake—and concern among insurers, reported RTS. Roughly 40,000 people received Wegovy under Switzerland’s mandatory health insurance in 2024, according an association representing […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
